Introduction: Polycystic ovary syndrome is a common chronic condition characterized by insulin resistance and hyperandrogenism. leading to significant health risks and impaired quality of life. Sodium-glucose transporter type 2 inhibitors have shown promise in improving the metabolic profile of women with polycystic ovary syndrome. However. https://foldlyers.shop/product-category/stemless/